Comvita, which uproduces health products from manuka honey and olive leaves, has bought an 85ha organic olive estate with potential to expand its production of olive leaf extracts by 130 percent over the next five years.
The price paid for Organic Olives (Aust) by Comvita's Australian subsidiary is undisclosed. The estate comprises some 7000 certified organic olive trees, with room for further plantings, and is in Coominya, on the shores of Lake Wivenhoe in south-eastern Queensland
The company recently reported clinical trials at Auckland University's Liggins Institute had found a beneficial impact from its olive leaf extracts on secretion of insulin and the action of insulin in overweight men.
The research has yet to be peer-reviewed and published, but is expected to boost global interest in the product.
"We're also scoping the possibility of building on this science, with additional clinical trials," Comvita chief executive Brett Hewlett says.
"The acquisition ... effectively future-proofs this rapidly growing part of our business. Together with fully developing our existing property, the development of our new purchase will provide the capacity to increase supply over the next five years by approximately 130 percent."
Comvita shares last traded on the NZX at $3.65, although none changed hands immediately after the announcement.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Housing stats show just about everything's getting worse
- Sir Bob Jones: Why the newspaper industry is deservedly dying
- Sri Lanka: PM's visit signals it's open for business
- Adobe, Microsoft, Google signal price rises from Oct 1 as GST net thrown wider (thanks, Spark)
- Craig expected to seek judge-only High Court review of jury's $1.27m damages decision
Most listened to
- Week in Review: a wrap of NBR Radio's top stories, interviews and analysis
- Matthew Hooton: Little leaves centre wide open for Peters and Greens
- ASB's Kim Mundy and Realestate.co.nz's Vanessa Taylor on the latest housing statistics
- Rob Hosking: Winston’s hour is coming
- Hunter's Corner: High stakes for both sides of Warminger case